2014 annual financial data
Dyne Therapeutics 2014 Operating cash flow margin
Direct answer
Operating cash flow margin was -4.23%.
Operating income was -318,000,000 USD and net income was -67,000,000 USD.
Operating cash flow was -62,000,000 USD.
Get free Dyne Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,466,000,000 USD
- Operating income
- -318,000,000 USD
- Net income
- -67,000,000 USD
- Operating cash flow
- -62,000,000 USD